🔗 Share this article

Treasury head Rachel Reeves has stated she is preparing "specific measures to tackle household expense issues" in the upcoming Budget.

Speaking to media outlets, she noted that curbing price rises is a joint task of both the government and the Bank of England.

The United Kingdom's price growth is forecast to be the highest among the Group of Seven developed nations this year and the following year.

Potential Utility Cost Interventions

Sources suggest the administration could intervene to bring down energy bills, for example by cutting the current 5% rate of VAT applied on energy.

An additional possibility is to reduce some of the government charges currently included in bills.

Fiscal Limitations and Analyst Predictions

The government will receive the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these measures.

The expectation from most experts is that Reeves will have to introduce tax increases or spending cuts in order to meet her self-imposed fiscal targets.

Earlier on the same day, analysis indicated there was a twenty-two billion pound gap for the Treasury chief to address, which is at the more modest range of forecasts.

"There's a shared job between the Bank of England and the government to bear down further on some of the causes of inflation," Reeves stated to reporters in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.

Tax Pledges and Global Concerns

While a great deal of the attention has been on probable tax rises, the chancellor said the most recent data from the OBR had not changed her pledge to campaign commitments not to raise tax levels on income tax, VAT or National Insurance.

She attributed an "uncertain world" with increasing international and trade concerns for the fiscal revenue measures, probably to be directed on those "wealthiest."

International Trade Disputes

Commenting on apprehensions about the United Kingdom's trade ties with China she said: "Our security interests invariably are paramount."

Last week's announcement by China to tighten trade restrictions on critical minerals and other resources that are crucial for advanced tech manufacturing led US President Donald Trump to threaten an additional 100% tariff on imports from the Asian country, increasing the prospect of an all-out trade war between the two largest economies.

The US Treasury Secretary labeled the Chinese action "economic coercion" and "a global supply chain power grab."

Inquired about considering the American proposal to participate in its dispute with China, the Chancellor said she was "very concerned" by China's measures and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the move was "harmful for the world economy and causes additional headwinds."

"In my view there are fields where we should address Chinese policies, but there are also valuable opportunities to trade with Chinese markets, including banking sector and other sectors of the economy. We've got to maintain that balance right."

The Treasury chief also affirmed she was collaborating with other major economies "on our own essential resources strategy, so that we are reduced dependence."

Health Service Drug Pricing and Investment

The Chancellor also recognized that the cost the National Health Service spends on pharmaceuticals could go up as a result of current negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and investment.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or abandoning investments in the United Kingdom, with several blaming the low prices they are getting.

Recently, the government science advisor said the cost the NHS pays for medicines would have to go up to halt businesses and pharmaceutical investment departing from the UK.

The Chancellor stated to media: "We have seen because of the payment system, that drug testing, new drugs have not been available in the UK in the way that they are in other European countries."

"Our aim is to ensure that patients getting care from the NHS are can obtain the finest essential drugs in the globe. And so we are examining these issues, and... aiming to obtain additional capital into Britain."